Rebus Holdings Inc. (RBSH)
Rebus Holdings Inc. is a biotechnology company focused on developing precision therapeutics for cancer treatment. Through its subsidiaries, the company is engaged in research and development efforts centered on RT-AR001, its lead asset. RT-AR001 is described as an adenosine receptor antagonist being evaluated for tumor infiltration and improved outcomes when delivered directly into a tumor. Rebus Holdings was incorporated in 2003 and is based in Westlake Village, California. Its common stock trades on OTC Markets under the symbol RBSH.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Market Cap |
|---|---|---|---|---|---|---|
|
OTC-RBSH
|
Not available
|
Not available
|
Not available
|
Weak
|
0.0%
|
0.032 K
|
